VNRX logo

VolitionRx Limited (VNRX)

Profile

Full Name

VolitionRx Limited

Ticker Symbol

VNRX

Country

United States

IPO

March 2, 2012

Indexes

Not included

Employees

85

Key Details

Price

$0.49(+1.02%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$1.23M(+59.10% YoY)

Annual EPS

-$0.31(+38.00% YoY)

PE ratio

-

Next earnings date

May 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Apr 11, 25 HC Wainwright & Co.
Buy
Apr 8, 25 HC Wainwright & Co.
Buy
Apr 1, 25 D. Boral Capital
Buy
Mar 31, 25 D. Boral Capital
Buy
Mar 20, 25 D. Boral Capital
Buy
Mar 13, 25 D. Boral Capital
Buy
Mar 12, 25 D. Boral Capital
Buy
Mar 4, 25 D. Boral Capital
Buy
Feb 6, 25 D. Boral Capital
Buy
Jan 29, 25 D. Boral Capital
Buy

Institutional Ownership

  • What is the ticker symbol for VolitionRx Limited?
  • Does VolitionRx Limited pay dividends?
  • What sector is VolitionRx Limited in?
  • What industry is VolitionRx Limited in?
  • What country is VolitionRx Limited based in?
  • When did VolitionRx Limited go public?
  • Is VolitionRx Limited in the S&P 500?
  • Is VolitionRx Limited in the NASDAQ 100?
  • Is VolitionRx Limited in the Dow Jones?
  • When was VolitionRx Limited's last earnings report?
  • When does VolitionRx Limited report earnings?
  • Should I buy VolitionRx Limited stock now?

What is the ticker symbol for VolitionRx Limited?

The ticker symbol for VolitionRx Limited is NYSE American:VNRX

Does VolitionRx Limited pay dividends?

No, VolitionRx Limited does not pay dividends

What sector is VolitionRx Limited in?

VolitionRx Limited is in the Healthcare sector

What industry is VolitionRx Limited in?

VolitionRx Limited is in the Medical Devices industry

What country is VolitionRx Limited based in?

VolitionRx Limited is headquartered in United States

When did VolitionRx Limited go public?

VolitionRx Limited's initial public offering (IPO) was on March 2, 2012

Is VolitionRx Limited in the S&P 500?

No, VolitionRx Limited is not included in the S&P 500 index

Is VolitionRx Limited in the NASDAQ 100?

No, VolitionRx Limited is not included in the NASDAQ 100 index

Is VolitionRx Limited in the Dow Jones?

No, VolitionRx Limited is not included in the Dow Jones index

When was VolitionRx Limited's last earnings report?

VolitionRx Limited's most recent earnings report was on Mar 31, 2025

When does VolitionRx Limited report earnings?

The next expected earnings date for VolitionRx Limited is May 14, 2025

Should I buy VolitionRx Limited stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page